Aktie A290650 L&C BIO CO., LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen L&C Bio Co., Ltd

Aktien

A290650

KR7290650001

A290650

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 26.04.2024 		% 5 Tage % 1. Jan.
19 650 KRW -1,65 % Intraday Chart für L&C Bio Co., Ltd -4,15 % -32,24 %
2023 L&C Bio Co., Ltd (KOSDAQ:A290650) kündigt einen Aktienrückkauf für 143.884 Aktien an. CI
2023 L&C BIO Co., Ltd genehmigt einen Rückkaufplan. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.
Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.
Plasmapp Co., Ltd. announced that it has received KRW 4.999997 billion in funding from DREAMTECH Co., Ltd., L&C Bio Co., Ltd
Plasmapp Co., Ltd. announced that it expects to receive KRW 4.999997 billion in funding from DREAMTECH Co., Ltd., L&C Bio Co., Ltd
Tranche Update on L&C Bio Co., Ltd's Equity Buyback Plan announced on November 23, 2023.
L&C Bio Co., Ltd's Equity Buyback announced on November 23, 2023, has closed with 143,884 shares, representing 0.63% for KRW 4,881 million.
L&C Bio Co., Ltd announces an Equity Buyback for 143,884 shares.
L&C BIO Co., Ltd authorizes a Buyback Plan.
L&C Bio Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Curexo Inc. announced that it has received KRW 40.49999982 billion in funding from L&C Bio Co., Ltd
L&C Bio Co., Ltd announced that it has received KRW 60 billion in funding
L&C Bio Co., Ltd announced that it expects to receive KRW 60 billion in funding
Curexo Inc. announced that it expects to receive KRW 40.49999982 billion in funding from L&C Bio Co., Ltd
NanoFocusRay Co., Ltd. announced that it expects to receive KRW 3.13 billion in funding from L&C Bio Co., Ltd
Netmarble : Skin care kiosk developer lululab secures funding
Lululab Inc. announced that it has received funding from L&C Bio Co., Ltd, Netmarble Corporation, CTK Investment Co., Ltd., Global Medical Research Center and other investors
Tranche Update on L&C BIO Co., LTD's Equity Buyback Plan announced on June 15, 2020.
L&C BIO Co., LTD's Equity Buyback announced on June 15, 2020, has closed with 91,996 shares, representing 1.25% for KRW 9,967.5 million.
L&C BIO Co., LTD announces an Equity Buyback for 91,996 shares.
L&C BIO Co., Ltd authorizes a Buyback Plan.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A290650 Aktie
  4. Nachrichten L&C Bio Co., Ltd
  5. Andere Sprachen